About: The impact of genomics on public health practice

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: The impact of genomics on public health practice Goto Sponge NotDistinct Permalink

An Entity of Type : schema:ScholarlyArticle, within Data Space : wasabi.inria.fr associated with source document(s)

Attributes	Values
type	Academic Article research paper schema:ScholarlyArticle
isDefinedBy	Covid-on-the-Web dataset
title	The impact of genomics on public health practice
Creator	Abubakar, I Burton, H Jackson, C
source	Medline; PMC
abstract	INTRODUCTION: Genomic science is developing rapidly, and engagement of public health professionals will be necessary to appraise new technologies and use them effectively. SOURCES OF DATA: We use established domains of public health and draw on the literature and expert knowledge to illustrate how genomic technologies give rise to new applications. AREAS OF AGREEMENT: Genomic technologies are useful in rare inherited disease, including population screening programmes, in health care and for surveillance, diagnosis and treatment of infectious disease. AREAS OF CONTROVERSY: It is less clear when and how genetic susceptibility testing will be used for common chronic disease prevention or protection from environmental hazards. GROWING POINTS: Developments in public health practice will be necessary to ensure rapid and effective implementation of genomic science. AREAS TIMELY FOR DEVELOPING RESEARCH: Public health researchers should address how to accelerate the implementation of genomics for health benefit in developed and developing countries.
has issue date	2014-12-01(xsd:dateTime)
bibo:doi	10.1093/bmb/ldu032
bibo:pmid	25368375
has license	no-cc
sha1sum (hex)	5e443d303e63f037d6907f51a37c5f08a1391a83
schema:url	https://doi.org/10.1093/bmb/ldu032
resource representing a document's title	The impact of genomics on public health practice
has PubMed Central identifier	PMC7110005
has PubMed identifier	25368375
schema:publication	Br Med Bull
resource representing a document's body	covid:5e443d303e63f037d6907f51a37c5f08a1391a83#body_text
is schema:about of	named entity 'IMPACT' named entity 'NECESSARY' named entity 'USE' named entity 'PUBLIC HEALTH' covid:arg/5e443d303e63f037d6907f51a37c5f08a1391a83 named entity 'PUBLIC HEALTH PRACTICE' named entity 'SCIENCE' named entity 'INTRODUCTION' named entity 'ENGAGEMENT' named entity 'NEW TECHNOLOGIES' named entity 'GENOMICS' named entity 'RAPIDLY' named entity 'DEVELOPING' named entity 'HEALTH PROFESSIONALS' named entity 'GENOMIC' named entity 'genomics' named entity 'Genomic science' named entity 'public health' named entity 'public health' named entity 'phylogenetic tree' named entity 'health promotion' named entity 'signalling pathway' named entity 'secondary prevention' named entity 'Western Australia' named entity 'genomic testing' named entity 'EGFR' named entity 'physical activity' named entity 'clinical management' named entity 'infectious disease' named entity 'genetic testing' named entity 'recessive' named entity 'infection' named entity 'MRSA' named entity 'sequencing technologies' named entity 'virulence' named entity 'molecular level' named entity 'health care' named entity 'clinical medicine' named entity 'genetic testing' named entity 'population health' named entity 'single-nucleotide polymorphism' named entity 'pregnancy' named entity 'occupational diseases' named entity 'public health' named entity 'genetic tests' named entity 'paediatrician' named entity 'health benefits' named entity 'CDC' named entity 'Mendelian' named entity 'stigmatization' named entity 'aetiologies' named entity 'risk factors' named entity 'disability' named entity 'cardiovascular disease' named entity 'antibiotic' named entity 'fluoroquinolones' named entity 'health-care' named entity 'disease outbreaks' named entity 'higher risk' named entity 'chromosomal disorders' named entity 'insulin' named entity 'genomics' named entity 'drug resistance' named entity 'methicillin resistant Staphylococcus aureus' named entity 'BRCA1' named entity 'genome-wide association studies' named entity 'heritable' named entity 'Whole-genome sequencing' named entity 'personalized medicine' named entity 'public health' named entity 'Human Genomics' named entity 'clonal' named entity 'environmental factors' named entity 'heritable' named entity 'rifampicin' named entity 'health-care systems' named entity 'England' named entity 'CDC' named entity 'single gene disorders'

Faceted Search & Find service v1.13.91 as of Mar 24 2020

Alternative Linked Data Documents: Sponger | ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3229 as of Jul 10 2020, on Linux (x86_64-pc-linux-gnu), Single-Server Edition (94 GB total memory)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2025 OpenLink Software